Ohio Patent of the Month – October 2024
SPR Therapeutics, Inc. is revolutionizing pain management with an innovative nerve stimulation method that targets efferent nerve fibers to reduce chronic pain without the need for invasive surgery. Unlike traditional approaches that focus on afferent sensory nerves, this breakthrough technology activates motor nerve fibers upstream of pain sites, providing lasting relief while avoiding discomfort or muscle fatigue.
At the core of the method is a precisely positioned electrode, integrated with a helically coiled percutaneous lead. This electrode stimulates the target nerve fibers at a therapeutically effective distance, typically over 1 mm away, ensuring precise action potential generation without affecting surrounding non-target nerves. The result is a controlled muscle response that interrupts pain signals and promotes recovery.
What sets SPR Therapeutics’ innovation apart is its non-invasive approach, leveraging external or implantable electrical stimulation devices. By stimulating efferent fibers, the method not only reduces pain but also induces physiological benefits like muscle activation, which can enhance mobility and circulation. Clinical applications span a wide range, including chronic pain, post-surgical recovery, and conditions resistant to conventional therapies.
The system is designed for ease of use and adaptability. Patients experience significant pain relief even after the stimulation sessions, with effects lasting up to 17 times longer than the treatment duration. This durable outcome minimizes the need for constant device use, improving quality of life and adherence to therapy.
By advancing neuromodulation technology with precision and patient comfort in mind, SPR Therapeutics is setting a new standard in pain management. This cutting-edge solution empowers patients to reclaim their lives, offering effective relief that is safe, minimally invasive, and tailored to individual needs. With this invention, the future of pain relief is more accessible and transformative than ever.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
